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Takayasu's disease is a giant cell arteritis that affects 
the aorta and its major branches, predominantly in 
young females during their second and third decade 
of life. The aetiology is unknown although infections, 
immunologic disorders, and hormonal influences 
have been implicated. 1-5 The disease, in its acute 
phase, causes an inflammatory infiltrate of all three 
arterial wall layers. In the chronic phase, the disease 
causes intimal proliferation and fibrotic changes in the 
media and adventitia that ultimately lead to stenosis 
and aneurysm formation. 6"7 
Classically the disease presents in two different 
phases. 8-11 During the acute phase, the patient com- 
plains of symptoms consistent with a virus like 
syndrome such as fever, weight loss, myalgia and 
arthralgia. Unless the patient also has pain over an 
involved artery such as the carotid, the examining 
physician rarely suspects Takayasu's disease in this 
phase. During the chronic phase, symptoms depend 
on the arteries involved. Claudication, hypertension, 
angina, cerebrovascular symptoms, and upper 
extremity ischaemic symptoms are common present- 
ing complaints. Physical examination reveals dimin- 
ished or absent pulses with accompanying vascular 
bruits. Sometimes, the diagnosis is suspected in a 
young patient with asymmetrical blood pressure 
measurements in the upper extremities. The examin- 
ing physician should consider Takayasu's disease in 
any young person, particularly female, presenting 
with pulse deficits or vascular bruits. There are no 
laboratory tests specific for Takayasu's disease. The 
sedimentation rate is commonly elevated but this is 
neither sensitive or specific for the disease. 2"9 
Arteriography is the definitive diagnostic test for 
Takayasu's disease. Lesions involving the common 
carotid, innominate, subdavian, and abdominal aorta 
are usually long tapered smooth stenoses or total 
12 occlusions. Stenoses of the renal artery are short 
lesions that usually begin beyond the renal artery 
orifice. Aneurysms occur, although less frequently 
than arterial stenosis or occlusion. The pulmonary 
arteries are involved in 50% of cases but this rarely 
becomes clinically significant. Serial arteriography 
performed at 3-6 month intervals also is useful to 
determine disease activity. 12"13 New lesions, not pre- 
sent previousl3~ indicate active disease provided this 
correlates with the patient's clinical course. 
Medical management consists of glucocorticoids 
2 9 10 12 13 administered for an initial 3 months. '" • • If this 
regimen is successful, then steroids are tapered over a 
1 year period. If the patient does not respond to 
steroids or develops recurrence of symptoms while 
the medication isbeing tapered, then either cyclophos- 
phamide or methotrexate are added to the medical 
regimen. 14 Recurrence of the disease is common and 
23% of all patients do not respond to any medical 
therapy. 12 It is the current belief that steroids will not 
cure the patient but can be palliative. 12 
Percutaneous transluminal angioplasty is not effec- 
tive for the long tapered stenoses commonly found in 
the carotid and subclavian arteries but can be used in 
the short segment stenoses of the renal arteries. 15'16 
The latter type stenoses present the angiographer with 
unique technical problems. Since the disease affects all 
layers of the arterial wall, the vessel itself becomes 
rigid and non compliant. Despite repeated attempts, it 
is sometimes difficult to eliminate the "waist" of the 
stenosis. Restenosis due to either non compliance of 
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the vessel or recurrent disease has been reported to be 
quite high after percutaneous transluminal angio- 
plastyJ 2"17 A more recent study, however, reported 
more encouraging long term results for renal artery 
lesions. 18 Arterial stents may ultimately improve these 
results in lesions treated by percutaneous trans- 
luminal angioplasty. 
Surgical intervention is appropriate to relieve symp- 
toms from arterial involvement by Takayasu's dis- 
ease. 17'19'2° Most operations hould be done electively 
when the disease is clinically inactive. However, 
operations in patients with active disease are possible 
with the expectation of good results and minimal 
morbidity. Bypass is usually the procedure of choice 
with both proximal and distal anastomoses performed 
in the segment of artery free of disease as determined 
by arteriography. Endarterectomy with patch graft is 
never indicated because the disease involves all three 
layers of the arterial wall presenting technical prob- 
lems that precludes the use of endarterectomy. 
Stroke from Takayasu's disease is not uncommon 
occurring as the initial presenting symptoms in 14% of 
patients. 19 Since all major cerebral vessels can be 
involved and the disease tends to produce smooth 
tapered lesions, it is the author's opinion that the 
stroke is not secondary to embolic phenomenon but 
more likely due to reduction of cerebral blood flow. 
Patients can present with occlusion of both subclavian 
arteries with stenoses of the carotid arteries. Sub- 
sequent occlusion of one of the carotids could cause a 
stroke. Therefore, to prevent stroke, bypass is recom- 
mended in those patients who have extensive involve- 
ment of innominate, carotid or proximal subclavian 
arteries. 19 Since the ascending aorta is infrequently 
involved, the bypass hould originate from this artery 
and anastomosed distally to the common carotid just 
proximal to its bifurcation. This area of the common 
carotid usually is not involved and even if the 
common carotid is occluded, the carotid bifurcation 
and the external and internal carotids are patent and 
free of disease. 
Hypertension is the major cause of morbidity and 
mortality in Takayasu's disease. With the frequent 
involvement of both subclavian arteries, hypertension 
is not diagnosed until the patient develops left 
ventricular hypertrophy or congestive heart failure. 
Since hypertension is due to renal artery involvement, 
an aggressive approach to renal artery stenosis is 
warrantedJ 2 A short segment stenosis of the renal 
artery initially should be treated with percutaneous 
transluminal angioplasty with or without arterial 
stent. If this is not possible or fails, then a bypass 
originating either from the uninvolved abdominal 
aorta, hepatic or splenic artery, is indicated. 
The subclavian artery is the vessel most commonly 
involved with Takayasu's disease. Subclavian steel 
rarely occurs because the narrowing or occlusion of 
the subclavian is extensive involving the artery both 
proximal and distal to the vertebral artery orifice. 
However, it is not uncommon for these patients to 
have disabling upper arm ischaemic symptoms. In 
addition, with both subclavian arteries involved, the 
diagnosis and treatment of hypertension becomes a
significant problem. Therefore it may be necessary to 
bypass the subclavian and axillary arteries with a graft 
from the ascending aorta to relieve upper extremity 
ischaemic symptoms or to provide an effective way to 
monitor arterial blood pressure. 
Due to the involvement of the infra-renal abdominal 
aorta, claudication can be severe and limiting in this 
young patient population. Rest pain, gangrene, or 
ulceration are unusual. Since disease usually spares 
the distal aorta, a bypass originating from the lower 
thoracic aorta to the left common iliac artery can 
provide blood flow to both legs. 2° 
With proper preoperative preparation, surgical pro- 
cedures on patients with Takayasu's disease can 
produce results comparable to those performed on 
patients with atherosclerotic disease. ~7"19 Morbidity 
and mortality should be minimal. Anastomotic false 
aneurysms rarely occur although a high incidence of 
graft stenoses has been reported. ~2"~9 This might be 
due to microscopic evidence of active disease at the 
site of the anastomosis even though the anastomosis 
was performed in an area free of disease by angiog- 
raphy. 12 Reduction in the incidence of stroke, 
improvement of hypertension, and alleviation of 
symptoms of upper and lower extremities i chaemic 
disease can be expected with properly performed 
procedures. 
Takayasu's disease is an illness that can be partic- 
ularly devastating because of involvement of all major 
arterial systems in a young patient population. Most 
surgeons have little experience with this unusual 
entity. However, if the surgeon appreciates the differ- 
ence between atherosclerotic occlusive disease and 
Takayasu, it is possible to treat these patients uccess- 
fully with good long-term results. Follow-up, how- 
ever, must be intense. Recurrences are common but 
can be managed. 
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